Pollen allergen Ole e 7 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

Ole e 7 is a nonspecific lipid transfer protein (nsLTP) allergen derived from olive pollen (Olea europaea), a major allergenic source in Mediterranean and Californian regions. The corresponding IgE antibodies (Ole e 7-specific IgE) are critical markers for diagnosing olive pollen allergy and associated pollen-food syndromes. This allergen belongs to the pan-allergen nsLTP family, known for its resistance to heat and digestion, enabling cross-reactivity with structurally similar proteins in foods like peach (Pru p 3) and other plant-derived allergens .

3.1. Prevalence and Sensitivity

  • High-Exposure Regions: Ole e 7 IgE positivity reaches 47–60% in olive-sensitive populations .

  • Co-Sensitization: Over 50% of patients tested for Ole e 7 and Pru p 3 exhibit co-sensitization, despite no cross-reactivity .

3.2. Symptomatology

  • Respiratory: Severe rhinitis, asthma exacerbation, and anaphylaxis linked to high pollen exposure .

  • Food Allergy: Cross-reactivity with Pru p 3 triggers peach-linked oral allergy syndrome (OAS) and anaphylaxis .

3.3. Diagnostic Relevance

  • Recombinant Allergens: rOle e 7 retains natural allergenic properties, aiding precise IgE detection .

  • Minority Allergen Impact: In 2–7% of olive-sensitive patients, Ole e 7 IgE is the sole marker, necessitating targeted testing .

Immunological Mechanisms

MechanismKey Findings
Epitope StructureIgE-binding epitopes overlap with Pru p 3 and other nsLTPs despite low sequence identity
Cross-ReactivityClinically relevant cross-reactivity with foods (peach, kiwi) and pollens (e.g., ryegrass)
HLA-DR2(15) AssociationLinked to heightened Ole e 7 sensitization and severe asthma

Therapeutic Implications

  • Allergen Immunotherapy (AIT): Ole e 7-specific IgE predicts adverse reactions to olive pollen AIT .

  • Pollen-Food Syndrome Management: Co-sensitization necessitates dietary avoidance of cross-reactive foods .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
Pollen allergen Ole e 7 (Allergen Ole e VII) (allergen Ole e 7) (Fragment)
Target Names
Pollen allergen Ole e 7,partial
Uniprot No.

Q&A

What is Ole e 7 and what are its main molecular properties?

Ole e 7 is an allergen isolated from olive tree (Olea europaea) pollen that belongs to the nonspecific lipid transfer protein (nsLTP) family. It is a non-glycosylated protein with a molecular mass ranging between 9875 d to 10,297 d (approximately 9.5 kDa) . The allergen exhibits a high degree of polymorphism, which contributes to its varied immunological properties . Initial characterization through N-terminal sequencing of 21 amino acid residues from two isoforms revealed no homology with proteins contained in database banks at the time of its initial isolation .

How does Ole e 7 compare structurally to other allergens in the Olea europaea pollen profile?

Ole e 7 is distinct from other olive pollen allergens such as Ole e 1 (the major olive pollen allergen), Ole e 2 (profilin), Ole e 9 (glucanase), and Ole e 10. While Ole e 1 can act as an immunological marker for sensitivity against the Oleaceae family, Ole e 7 belongs to a highly conserved protein family found in both phylogenetically related and unrelated species . This conservation pattern explains its cross-reactivity potential with nsLTPs from other sources, including non-pollen allergens.

What are the recommended laboratory protocols for detecting and isolating Ole e 7?

The isolation of Ole e 7 involves a multi-step purification process. The recommended protocol includes:

  • Initial extraction of olive pollen proteins

  • Fractionation using gel filtration chromatography

  • Further purification by reverse-phase HPLC

  • Verification of allergenic fractions using immunoblotting and ELISA with sera from olive-allergic patients

This purification strategy has been validated and can serve as a model for isolating other allergens with similar properties. For detection in patient samples, specific IgE (sIgE) assays using commercial systems such as ImmunoCAP are effective, with levels >0.35 kU/L considered positive .

How can researchers characterize the molecular properties of Ole e 7 isoforms?

Molecular characterization of Ole e 7 isoforms requires several complementary techniques:

  • Acid hydrolysis followed by amino acid analysis to determine composition

  • Mass spectrometry for accurate molecular weight determination, especially important given the polymorphic nature of Ole e 7

  • N-terminal sequencing via Edman degradation to identify sequence variations

  • Recombinant production of Ole e 7 variants for structural studies and immunological comparisons

For comprehensive epitope mapping, novel immunocapture approaches coupled with liquid chromatography and high-resolution mass spectrometry have proven effective in identifying IgE-binding linear epitopes .

What functional assays are used to evaluate the biological activity of Ole e 7?

To assess the biological activity of Ole e 7 and its potential cross-reactivity:

  • Basophil Activation Test (BAT): This cellular assay measures the release of mediators from basophils when stimulated with the allergen. The protocol typically uses recombinant Ole e 7 at 10 μg/mL as the stimulus, with cell staining performed using anti-human CD63 FITC/CD123 PE/HLA-DR PerCP antibody cocktail. PBS serves as a negative control and N-formyl-methionyl-leucyl-phenylalanine (fMLP) as a positive control .

  • IgE-binding assays: Microplates coated with purified mouse anti-human IgE (0.2 μg/well) are used to capture IgE from patient sera. After blocking and washing steps, the plates are incubated with Ole e 7 peptides to assess binding capacity .

These functional assays provide critical information about the allergen's ability to trigger allergic responses and its cross-reactivity potential.

How is Ole e 7 sensitization associated with clinical symptoms in olive pollen allergy patients?

Ole e 7 sensitization has been significantly associated with more severe clinical manifestations of olive pollen allergy. Research indicates that patients with Ole e 7-specific IgE antibodies often experience more intense allergic responses, including anaphylactic reactions . This association with severity makes Ole e 7 sensitization an important clinical marker for risk assessment in olive pollen allergy management.

Additionally, in high-exposure areas supporting olive pollen counts over 5000 grains/m³, laboratory data show a positivity rate of 72% for Ole e 7-specific IgE , further highlighting its clinical relevance in regions with significant olive cultivation.

What methodological approaches should be used to investigate the relationship between Ole e 7 sensitization and asthma severity?

To investigate the relationship between Ole e 7 sensitization and asthma severity, researchers should employ a multifaceted approach:

  • Comprehensive clinical assessment: Document detailed patient history including symptom frequency, severity, medication use, and exacerbation patterns

  • Specific IgE quantification: Measure Ole e 7-specific IgE levels using standardized immunoassays

  • Pulmonary function testing: Assess objective measures of airway obstruction

  • Controlled exposure studies: In appropriate settings, monitor respiratory responses following controlled exposure to purified allergen components

  • Longitudinal follow-up: Track asthma days and symptom severity over time

Previous studies have demonstrated that patients with Ole e 7-specific IgE antibodies experience significantly more severe bronchial asthma compared to non-sensitized individuals, with higher numbers of asthma days (comparable to findings with Ole e 10 sensitization) .

How should researchers design studies to investigate Ole e 7's role in pollen-food allergy syndrome?

When designing studies to investigate Ole e 7's role in pollen-food allergy syndrome, researchers should:

  • Establish clear patient categorization: Based on sensitization profiles (e.g., monosensitized to Ole e 7, monosensitized to food LTPs like Pru p 3, or sensitized to both)

  • Implement comprehensive diagnostic protocols:

    • Detailed clinical history focusing on both respiratory and food-related symptoms

    • Skin prick testing with both pollen and food allergens

    • Specific IgE quantification to relevant allergens

    • Basophil activation tests to assess cross-reactivity

  • Perform controlled food challenges: Under medical supervision in appropriate cases

  • Analyze geographic and environmental variables: Particularly olive pollen exposure levels

  • Consider genetic factors: Such as HLA haplotyping which may influence sensitization patterns

Research has shown that anti-Ole e 7 IgE is significantly associated with fruit anaphylaxis , and in areas with high olive pollen counts, more than half of patients tested for both Ole e 7 and Pru p 3 (peach LTP) are co-sensitized .

What methodological approaches can identify cross-reactive epitopes between Ole e 7 and other nsLTPs?

To identify cross-reactive epitopes between Ole e 7 and other nsLTPs (such as Pru p 3 from peach), researchers should employ:

  • Epitope mapping techniques:

    • Novel immunocapture approaches

    • Liquid chromatography coupled to high-resolution mass spectrometry

    • Peptide microarrays with overlapping synthetic peptides covering the entire sequence

  • Inhibition assays:

    • ELISA inhibition using recombinant proteins

    • Immunoblot inhibition to confirm shared epitopes

  • In vitro cellular assays:

    • Basophil activation tests with recombinant allergens (rOle e 7 and rPru p 3)

    • T-cell proliferation assays to assess T-cell epitope cross-recognition

A previous study found that 30% of patients sensitized to Ole e 7 without detectable sIgE to Pru p 3 showed positive BAT results when stimulated with recombinant Pru p 3, indicating potential cross-reactivity at the effector cell level despite the absence of detectable cross-reactive IgE .

How can researchers distinguish between co-sensitization and cross-reactivity to Ole e 7 and other nsLTPs?

Distinguishing between true cross-reactivity and co-sensitization requires a systematic approach:

  • Sequential immunoadsorption studies:

    • Pre-adsorb patient sera with one allergen before testing reactivity to the other

    • Compare binding patterns before and after adsorption

  • Recombinant allergen testing:

    • Use of purified recombinant allergens in both in vitro and in vivo tests

    • Site-directed mutagenesis of potential cross-reactive epitopes

  • Epitope-specific antibody analysis:

    • Production of monoclonal antibodies against specific epitopes

    • Competitive binding assays with different nsLTPs

  • Clinical correlation:

    • Compare clinical reactivity patterns with immunological findings

    • Assess symptom provocation with different allergens

Data from studies categorizing patients based on Ole e 7 and Pru p 3 sIgE profiles (monosensitized to Ole e 7, monosensitized to Pru p 3, or sensitized to both) provide a framework for such investigations .

How should researchers approach the characterization of Ole e 7 polymorphisms and their impact on allergenicity?

To characterize Ole e 7 polymorphisms and assess their impact on allergenicity, researchers should:

  • Implement comprehensive protein sequencing:

    • Complete amino acid sequencing of multiple Ole e 7 isoforms

    • Mass spectrometry analysis to identify post-translational modifications

  • Conduct structural biology studies:

    • X-ray crystallography or NMR spectroscopy to determine 3D structures

    • Molecular modeling to predict the impact of sequence variations on protein folding

  • Perform comparative immunological testing:

    • IgE binding assays with different isoforms

    • Basophil activation tests to assess functional consequences of polymorphisms

    • T-cell epitope analysis to evaluate differences in immunological processing

  • Correlate genotypic and phenotypic data:

    • Analyze the relationship between specific Ole e 7 variants and clinical manifestations

    • Investigate geographical distribution of different isoforms relative to sensitization patterns

Given that Ole e 7 exhibits a high degree of polymorphism , understanding how these variations affect allergenicity could provide important insights for diagnostic and therapeutic applications.

What experimental approaches should be used to investigate the immunological mechanisms of Ole e 7 in severe allergic reactions?

To investigate the immunological mechanisms of Ole e 7 in severe allergic reactions:

  • Animal models:

    • Develop murine models sensitized to Ole e 7

    • Evaluate respiratory and systemic responses to controlled challenges

  • Ex vivo human studies:

    • Analyze cytokine production profiles from peripheral blood mononuclear cells (PBMCs)

    • Assess basophil and mast cell activation thresholds using cells from sensitized patients

  • Immune profiling:

    • Characterize T-cell receptor repertoires in Ole e 7-reactive lymphocytes

    • Analyze IgE affinity and avidity to Ole e 7 in patients with different clinical phenotypes

  • Genetic association studies:

    • Investigate HLA associations with Ole e 7 sensitization and reaction severity

    • Examine single nucleotide polymorphisms (SNPs) in genes involved in allergic inflammation

Research has demonstrated that Ole e 7 sensitization is associated with more severe clinical symptoms in patients who have experienced anaphylactic reactions , suggesting unique immunological mechanisms that merit further investigation.

How can transcriptomic and proteomic approaches enhance our understanding of Ole e 7 expression patterns in different olive tree varieties?

Transcriptomic and proteomic approaches offer powerful tools for investigating Ole e 7 expression:

  • RNA sequencing (RNA-Seq):

    • Compare Ole e 7 transcript levels across olive tree varieties

    • Analyze gene expression under different environmental conditions

    • Identify regulatory elements controlling allergen expression

  • Quantitative proteomics:

    • Use isotope-coded protein labeling (ICPL) or isobaric tags for relative and absolute quantitation (iTRAQ)

    • Measure Ole e 7 protein abundance in pollen from different cultivars

    • Identify post-translational modifications that may affect allergenicity

  • Single-cell analysis:

    • Characterize cell-specific expression patterns within pollen grains

    • Investigate developmental regulation of Ole e 7 production

  • Environmental influence assessment:

    • Monitor Ole e 7 expression under different climate conditions

    • Evaluate the impact of pollution, temperature, and humidity on allergen expression

These advanced approaches could help explain the observed variations in Ole e 7 prevalence among different geographical populations and potentially identify olive varieties with reduced allergenic potential for future agricultural considerations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.